Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06884943 · ClinicalTrials.gov registry record · Phase 2

Generalization With AI Navigation Using StaRt

A Phase 2 study of Speech Sound Disorder, sponsored by New York University.

Recruiting
Registry status
Phase 2
Development phase
76
Enrollment target
2
Study locations

NCT06884943: Recruiting Phase 2 study of Speech Sound Disorder, sponsored by New York University.

NCT06884943 is a Phase 2 study of Speech Sound Disorder that is actively recruiting participants, run by New York University. The registered enrollment target is 76 participants, below the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (10% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06884943, a Phase 2 study of Speech Sound Disorder, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
Phase 2
Development phase
76 participants
Enrollment target
2
Study locations

Study Summary

Speech Sound Disorder (SSD) affects a significant portion of school-aged children, leading to social and emotional challenges that can persist into adolescence and adulthood. The number of productions necessary for a remediated speech sound to generalize to connected speech is challenging to achieve in practice, leading clinicians to call for accessible, reliable resources allowing children to continue therapy outside of direct clinical interactions. Artificial intelligence (AI) tools hold promise as a means to extend direct service delivery in speech-language pathology, but research investigating the topic has been limited. This study (Generalization with AI Navigation using staRt, or GAINS) will measure the effects of a course of AI-mediated home practice intended to promote generalization of gains made through biofeedback treatment in a related study, Visual-acoustic Intervention with Service Delivery In-person and Via Telepractice Trial (VISIT; NCT06517225).

Primary Outcome

To assess generalization of treatment gains to untreated words, participants will be assessed with standard probes (30 words \[considered the primary target\], 20 syllables, and 10 sentences containing /r/ in various phonetic contexts). Stimuli in each probe will be presented individually in randomized order with blocking by stimulus type (word, syllable, sentence). Individual words will be isolated from the audio record of each word probe and presented in randomized order for binary rating (cor

Conditions Studied

Interventions

  • BEHAVIORAL Treatment as Usual (TAU)
  • BEHAVIORAL AI-guided maintenance training with visual-acoustic biofeedback

Study Locations (2)

New Jersey

  • Montclair State University - Bloomfield

New York

  • Syracuse University - Syracuse

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2024-12-18
Est. Completion 2029-07-01
Phase Phase 2
New York University

83 total trials

What NCT06884943 shows while recruiting

NCT06884943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 84-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (10% lower).

The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.

NCT06884943 reports a single indexed study location in New Jersey, New York.

Frequently Asked Questions

What is clinical trial NCT06884943 about?

NCT06884943 is a clinical study titled "Generalization With AI Navigation Using StaRt". Speech Sound Disorder (SSD) affects a significant portion of school-aged children, leading to social and emotional challenges that can persist into adolescence and adulthood. The number of productions necessary for a remediated speech sound to generalize to connected speech is challenging to achieve...

What is the current status of trial NCT06884943?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 76 participants. The study started on 2024-12-18. Estimated completion is 2029-07-01.

What conditions does trial NCT06884943 study?

This clinical trial studies the following conditions: Speech Sound Disorder.

What interventions are being tested in trial NCT06884943?

The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), AI-guided maintenance training with visual-acoustic biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT06884943?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06884943 being conducted?

This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech Sound Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06884943's enrollment target sits among peer trials

76 6th of 15 higher than 9 of 15 other Speech Sound Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06884943, the US trial registry maintained by the National Library of Medicine. NCT06884943 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.